Hormone replacement therapy and the risk of breast cancer. Nested case- control study in a cohort of Swedish women attending mammography screening

International Journal of Cancer

Volumn 72, Issue 5, 1997, Pages 758-761

  Persson, Ingemar ^a   Thurfjell, Erik ^a   Bergström, Reinhold ^a   Holmberg, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRIOL; GESTAGEN; NORETHISTERONE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DRUG MIXTURE; FEMALE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MAMMOGRAPHY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGESTERONE; SWEDEN; TIME FACTORS;

EID: 0030841396     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970904)72:5<758::AID-IJC9>3.0.CO;2-R     Document Type: Article

References (15)

1. ADAMI, H.O. and PERSSON, I., Hormone replacement and breast cancer. A remaining controversy. J. amer. med. Ass., 274, 178-179 (1995).
2. BERGKVIST, L., ADAMI, H.O., PERSSON, I., HOOVER, R. and SCHAIRER, C., The risk of breast cancer after estrogen and estrogen-progestin replacement. N. Engl. J. Med., 321, 293-297 (1989).
3. BRINTON, L.A. and SCHAIRER, C., Estrogen replacement therapy and breast cancer risk. Epidemiol. Rev., 15, 66-79 (1993).
4. CAMPAGNOLI, C., BIGLIA, N. and SISMONDI, P., Hormone replacement therapy and breast cancer risk. J. amer. med. Ass., 275, 1159 (1996).
5. COLDITZ, G.A., HANKINSON, S.E., HUNTER, D.J., WILLET, W., MANSON, J.A., STAMPFER, M., HENNEKENS, C., ROSNER, B. and SPEITZER, F., The use of estrogens and progestins and the risk of breast cancer in post menopausal women. N. Engl. J. Med., 332, 1589-1593 (1995).
6. EWERTZ., M., Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int. J. Cancer, 42, 832-838 (1988).
7. HARRIS, R.E., NAMBOODIRI, K.K., FARRAR, W.B., SOLANO, S.M. and WYNDER, E.L., Hormone replacement therapy and breast cancer risk. J. amer. med. Ass., 275, 1158 (1996).
8. HUNT, K., VESSEY, M., MCPHERSON, K. and COLEMAN, M., Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Brit. J. Obstet. Gynecol., 94, 620-635 (1987).
9. KEY, T.J.A. and PIKE, M.C., The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Europ. J. Cancer. Clin. Oncol., 24, 29-43 (1988).
10. NEWCOMB, P., LONGNECKER, M., STORER, B., MITTENDORF, R., BARON, J., CLAP, P., BOGDAN, G. and WILLETT, W., Long-term hormone replacement therapy and risk of breast cancer in post-menopausal women. Amer. J. Epidemiol., 142, 788-795 (1995).
11. STANFORD, J.L. and THOMAS, D.B., Exogenous progestins and breast cancer. Epidemiol. Rev., 15, 98-105 (1993).
12. STANFORD, J.L., WEISS, N.S., VOIGHT, L.F., DALING, J.R., HABEL, L.A. and ROSSING, M.A., Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J. amer. med. Ass., 274, 137-142 (1995).
13. STEINBERG, K.K., THACKER, S.B., SMITH, J.S., STROUP, D., ZACK, M., FLANDERS, D. and BERKELMAN, R., A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. J. amer. med. Ass., 265, 1985-1990 (1991).
14. THURFJELL, E.L. and LINDGREN, J.A.Å, Population-based mammography screening in Swedish clinical practice: prevalence and incidence screening in Uppsala county. Radiology, 193, 351-357 (1994).
15. YANG, C.P., DALING, J.R., BAND, P.R., GALLAGHER, R.P., WHITE, E. and WEISS, N.S., Non-contraceptive hormone use and risk of breast cancer. Cancer Causes Control, 3, 475-479 (1992).